Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aef0117
2. 1610878-71-1
3. Schembl21295170
4. Glxc-27677
5. Ex-a8305
6. Da-50250
7. Hy-156831
8. Cs-0898104
9. 3?-(4-methoxybenzyloxy)pregn-5-en-20-one; 1-((3s,8s,9s,10r,13s,14s,17s)-3-((4-methoxybenzyl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)ethan-1-one
| Molecular Weight | 436.6 g/mol |
|---|---|
| Molecular Formula | C29H40O3 |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 35.5 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 735 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
23
PharmaCompass offers a list of AEF0117 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AEF0117 manufacturer or AEF0117 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AEF0117 manufacturer or AEF0117 supplier.
PharmaCompass also assists you with knowing the AEF0117 API Price utilized in the formulation of products. AEF0117 API Price is not always fixed or binding as the AEF0117 Price is obtained through a variety of data sources. The AEF0117 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AEF0117 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AEF0117, including repackagers and relabelers. The FDA regulates AEF0117 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AEF0117 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AEF0117 supplier is an individual or a company that provides AEF0117 active pharmaceutical ingredient (API) or AEF0117 finished formulations upon request. The AEF0117 suppliers may include AEF0117 API manufacturers, exporters, distributors and traders.
AEF0117 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AEF0117 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AEF0117 GMP manufacturer or AEF0117 GMP API supplier for your needs.
A AEF0117 CoA (Certificate of Analysis) is a formal document that attests to AEF0117's compliance with AEF0117 specifications and serves as a tool for batch-level quality control.
AEF0117 CoA mostly includes findings from lab analyses of a specific batch. For each AEF0117 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AEF0117 may be tested according to a variety of international standards, such as European Pharmacopoeia (AEF0117 EP), AEF0117 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AEF0117 USP).
